Creative Planning’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-171
| Closed | -$1.81K | – | 3001 |
|
|
2023
Q4 | $1.81K | Buy |
171
+6
| +4% | +$72 | ﹤0.01% | 2737 |
|
|
2023
Q3 | $3.26K | Hold |
165
| – | – | ﹤0.01% | 2768 |
|
|
2023
Q2 | $12.6K | Hold |
165
| – | – | ﹤0.01% | 2533 |
|
|
2023
Q1 | $15.6K | Buy |
165
+16
| +11% | +$1.52K | ﹤0.01% | 2427 |
|
|
2022
Q4 | $14.5K | Sell |
149
-26
| -15% | -$3.77K | ﹤0.01% | 2331 |
|
|
2022
Q3 | $45K | Hold |
175
| – | – | ﹤0.01% | 2122 |
|
|
2022
Q2 | $32K | Buy |
175
+2
| +1% | +$191 | ﹤0.01% | 2096 |
|
|
2022
Q1 | $17K | Sell |
173
-9
| -5% | -$1.16K | ﹤0.01% | 2155 |
|
|
2021
Q4 | $30K | Sell |
182
-2
| -1% | -$440 | ﹤0.01% | 2027 |
|
|
2021
Q3 | $50K | Buy |
184
+12
| +7% | +$3.67K | ﹤0.01% | 1996 |
|
|
2021
Q2 | $68K | Sell |
172
-14
| -8% | -$6.54K | ﹤0.01% | 1911 |
|
|
2021
Q1 | $100K | Sell |
186
-8
| -4% | -$4.98K | ﹤0.01% | 2248 |
|
|
2020
Q4 | $73K | Sell |
194
-6
| -3% | -$2.39K | ﹤0.01% | 2066 |
|
|
2020
Q3 | $76K | Hold |
200
| – | – | ﹤0.01% | 1863 |
|
|
2020
Q2 | $99K | Sell |
200
-37
| -16% | -$16.5K | ﹤0.01% | 1663 |
|
|
2020
Q1 | $87K | Buy |
237
+17
| +8% | +$8.8K | ﹤0.01% | 1559 |
|
|
2019
Q4 | $156K | Sell |
220
-335
| -60% | -$231K | ﹤0.01% | 1690 |
|
|
2019
Q3 | $357K | Sell |
555
-46
| -8% | -$36.5K | ﹤0.01% | 1257 |
|
|
2019
Q2 | $525K | Buy |
601
+100
| +20% | +$68.8K | ﹤0.01% | 1051 |
|
|
2019
Q1 | $289K | Buy |
501
+100
| +25% | +$41.8K | ﹤0.01% | 1344 |
|
|
2018
Q4 | $113K | Sell |
401
-70
| -15% | -$27.7K | ﹤0.01% | 1614 |
|
|
2018
Q3 | $226K | Hold |
471
| – | – | ﹤0.01% | 1593 |
|
|
2018
Q2 | $213K | Buy |
471
+7
| +2% | +$4.44K | ﹤0.01% | 1606 |
|
|
2018
Q1 | $273K | Sell |
464
-2
| -0.4% | -$1.25K | ﹤0.01% | 1399 |
|
|
2017
Q4 | $289K | Buy |
466
+68
| +17% | +$48.9K | ﹤0.01% | 1382 |
|
|
2017
Q3 | $366K | Sell |
398
-8
| -2% | -$7.11K | ﹤0.01% | 1211 |
|
|
2017
Q2 | $379K | Buy |
406
+20
| +5% | +$19.6K | ﹤0.01% | 1160 |
|
|
2017
Q1 | $367K | Buy |
386
+287
| +290% | +$267K | ﹤0.01% | 1146 |
|
|
2016
Q4 | $80K | Buy |
99
+26
| +36% | +$23.4K | ﹤0.01% | 2020 |
|
|
2016
Q3 | $62K | Sell |
73
-133
| -65% | -$107K | ﹤0.01% | 2190 |
|
|
2016
Q2 | $169K | Buy |
206
+134
| +186% | +$146K | ﹤0.01% | 1336 |
|
|
2016
Q1 | $80K | Buy |
72
+20
| +38% | +$20.5K | ﹤0.01% | 1770 |
|
|
2015
Q4 | $65K | Sell |
52
-2
| -4% | -$3.31K | ﹤0.01% | 1908 |
|
|
2015
Q3 | $74K | Buy |
+54
| New | +$89.1K | ﹤0.01% | 1776 |
|
|
2015
Q2 | – | Sell |
-7
| Closed | -$11K | – | 2809 |
|
|
2015
Q1 | $11K | Buy |
+7
| New | +$10.4K | ﹤0.01% | 3145 |
|
|
2014
Q4 | – | Sell |
-3
| Closed | -$1K | – | 4339 |
|
|
2014
Q3 | $1K | Buy |
+3
| New | +$1.45K | ﹤0.01% | 3868 |
|
|
2014
Q1 | – | Sell |
-40
| Closed | -$26K | – | 3748 |
|
|
2013
Q4 | $26K | Buy |
+40
| New | +$23.8K | ﹤0.01% | 2034 |
|
Other funds holding TCRT
MP
CB
ACM
Creative Planning's TCRT Position: Q1 2024 in Review
Creative Planning sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 171 shares — an estimated $1.81K sold.
Creative Planning first reported a position in TCRT in Q4 2013 and held it in 37 quarters. The position peaked at $525K in Q2 2019. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.
- Creative Planning reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
- Creative Planning sold 171 Alaunos Therapeutics shares in Q1 2024, an estimated $1.81K.
- Creative Planning first reported a position in Alaunos Therapeutics in Q4 2013 and held it in 37 quarters.
- Creative Planning's Alaunos Therapeutics position peaked at $525K in Q2 2019.
- 45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.
Based on Creative Planning's 13F filing for Q1 2024, filed 13 May 2024.